Association Lp-PLA2 Gene Polymorphisms with Coronary Heart Disease

Table 3

Genotype and allele frequencies in the CHD group with the control group.

Variants	Genotypes	CHD (, %)	Controls (, %)	OR	95% low	95% high	值
R92H	GG; GA; AA	198 (69.96%); 70 (24.73%); 15 (5.30%)	197 (75.48%); 60 (22.99%); 4 (1.53%)	1.321	0.904	1.932	0.1496
	G; A	466 (82.33%); 100 (17.67%)	454 (86.97%); 68 (13.03%)	1.433	1.026	2.001	0.0343
V279F	CC; CA; AA	251 (88.69%); 31 (10.95%); 1 (0.35%)	242 (92.72%); 15 (5.75%); 4 (1.53%)	1.624	0.896	2.943	0.1073
	C; A	533 (94.17%); 33 (5.83%)	499 (95.59%); 23 (4.41%)	1.343	0.778	2.319	0.2881
A379V	GG; GA; AA	199 (70.32%); 77 (27.21%); 7 (2.47%)	175 (67.05%); 76 (29.12%); 10 (3.83%)	0.859	0.598	1.235	0.4113
	G; A	475 (83.92%); 91 (16.08%)	426 (81.61%); 96 (18.39%)	0.850	0.620	1.165	0.3123